Changing HIV Infection–Related Mortality Rate and Causes of Death Among Persons With HIV Infection Before and After the Introduction of Highly Active Antiretroviral Therapy
Free accessResearch articleFirst published online September, 2006
Changing HIV Infection–Related Mortality Rate and Causes of Death Among Persons With HIV Infection Before and After the Introduction of Highly Active Antiretroviral Therapy
Objectives: To compare the trends in death rates and the causes of deaths before and after the introduction of highly active antiretroviral therapy. Methods: This is a retrospective study based on chart review of all HIV-related deaths between January 1997 and December 2005. Results: The HIV-specific death rate declined from 34.12 per 100 000 adult population during 1997-1999 to 17.21 per 100 000 adult population during 2003-2005 when highly active anti-retroviral therapy was available. The proportion of all HIV-related deaths among persons newly diagnosed with HIV during the terminal hospitalization decreased from 93% during 1997-1999 to 28% during 2003-2005. Opportunistic infection was at least one of the causes of death in nearly half of all cases. Conclusions: Although, the HIV-specific death rates have declined significantly since the introduction of highly active antiretroviral therapy, HIV infection continues to contribute to the premature deaths among adults, mainly because of the late presentation.
Jensen-Fangel S, Pedersen L, Pedersen C, et al. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. AIDS. 2004; 18:89-97.
2.
Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22-29.
3.
Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338: 853-860.
4.
Egger M, Hirschel B, Francioli P, et al. Impact of new anti-retroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ. 1997;315: 1194-1199.
5.
Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active anti-retroviral therapy, San Francisco, 1994-1998. J Infect Dis.2002;186:1023-1027. Epub ahead of print September 13, 2002.
6.
Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91-98.
7.
Vandentorren S, Mercie P, Marimoutou C, et al, for Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997. Eur J Epidemiol. 2001;17:7-10.
8.
Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis. 2003;36:1030-1038. Epub ahead of print April 2, 2003.
9.
Metz SA, Hutchins GM, Bacellar H, Besley D, Kingsley LA, Chmiel JS. A comparison of autopsy and death certificate findings among AIDS-related deaths in the Multicenter AIDS Cohort Study. Int Conf AIDS. 1993;9:659-659.
10.
Lewden C, Sobesky M, Cabie A, et al, for Grouped d'etude “Mortalite 2000”. Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART). Med Mal Infect. 2004;34:286-292.
11.
Country profile–Barbados. Pan American Health Organization (Regional Office of the World Health Organization) Web site. Available at: http://www.paho.org/English/AIS/cp_052.htm. Accessed January 17, 2006.
12.
Caribbean Epidemiology Centre/Pan American Health Organization/WHO. Status and trends: analysis of the Caribbean HIV/AIDS epidemic 1982-2002. Port of Spain, Republic of Trinidad and Tobago: Caribbean Epidemiology Centre; 2004.
13.
Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC. CD4 cell counts in adults with newly diagnosed HIV infection in Barbados. Rev Panam Salud Publica. 2004;16:718-725.
14.
Rutledge SE, Abell N. Awareness, acceptance, and action: an emerging framework for understanding AIDS stigmatizing attitudes among community leaders in Barbados. AIDS Patient Care STDS. 2005;19:186-199.
15.
Kumar A, Waterman A, Kumari G, Carter AO. Prevalence and correlates of HIV serostatus disclosure: a prospective study among HIV-infected post parturient women in Barbados. Poster presented at: the XV International AIDS Conference; July 11-13, 2004; Bangkok, Thailand.
16.
Lewden C, Salmon D, Morlat P, et al, for Mortality 2000 Study Group. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121-130. Epub ahead of print November 23, 2004.
17.
Bonnet F, Lewden C, May T, et al, for Mortality 2000 Study Group. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37:482-487.
18.
Bellamy R. Sangeetha S. Paton NI. Causes of death among patients with HIV in Singapore from 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS). HIV Med. 2004;5:289-295.
19.
Ansari NA, Kombe AH, Kenyon TA. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis. 2002;6:55-63.
20.
Kravcik S, Hawley-Foss N, Victor G. Causes of death of HIV-infected persons in Ottawa, Ontario, 1984-1995.Arch Intern Med. 1997;157:2069-2073.
